1.57 BONUS! Control Arm Quality in RCTs Leading to Anticancer Drug FDA Approval with Dr. Talal Hilal
In this BONUS episode, we interview Dr. Talal Hil…
Plenary Session - inactive due to federal service · Plenary Session - inactive due to federal service
May 2, 201933m 33sExplicit
Audio is streamed directly from the publisher (feeds.soundcloud.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this BONUS episode, we interview Dr. Talal Hilal of the Mayo Clinic on his paper that was published today in JAMA Oncology, titled "Analysis of Control Arm Quality in Randomized Clinical Trials Leading to Anticancer Drug Approval by the US Food and Drug Administration".
Control Arm Quality: doi.org/10.1001/jamaoncol.2019.0167
Back us on Patreon! www.patreon.com/plenarysession
Topics
medicineoncologyhealthpolicy